MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EVMN has $322,455K in assets. $17,900K in debts. $48,318K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2035.79%
Quick Ratio
2035.79%
Cash Ratio
455.70%
Debt to Asset Ratio
5.55%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, non-c...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
48,318 44,063 26,818
Short-term investments
163,146 105,137 49,244
Prepaid expenses and other current assets
4,391 4,278 5,879
Total current assets
215,855 153,478 81,941
Operating lease right-of-use assets, net
7,930 1,469 160
Property and equipment, gross
-2,553 -
Less accumulated depreciation and amortization
-1,559 -
Property and equipment, net
1,640 994 970
Long-term investments
95,548 67,489 -
Restricted cash
1,409 1,415 1,412
Other non-current assets
73 101 61
Total assets
322,455 224,946 84,544
Accounts payable
4,045 7,756 3,576
Accrued liabilities
4,734 9,547 6,309
Operating lease liability, current portion
1,253 242 160
Other current liabilities
571 364 371
Total current liabilities
10,603 17,909 10,416
Operating lease liability, non-current portion
6,768 1,290 -
Other non-current liabilities
--261
Financing lease liability
529 181 -
Total liabilities
17,900 19,380 10,677
Convertible preferred stock 0.0001 par value - 157,657,729 shares authorized at september 30, 2025 and december 31, 2024, respectively, 157,657,729 and 116,716,142 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively (liquidation preference 275,611 and 210,328 at september 30, 2025 and december 31, 2024, respectively)
--257,004
Common stock, par value 0.0001 - 500,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 36,018,372 and 31,524,093 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
4 3 -
Additional paid-in capital
547,314 426,652 9,679
Accumulated deficit
-242,763 -221,089 -192,816
Total stockholders' equity
304,555 205,566 -183,137
Total liabilities and stockholders' equity
322,455 224,946 84,544
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$163,146K Cash and cashequivalents$48,318K Prepaid expenses andother current assets$4,391K Total current assets$215,855K Long-term investments$95,548K Operating leaseright-of-use assets, net$7,930K Property and equipment,net$1,640K Restricted cash$1,409K Other non-currentassets$73K Total assets$322,455K Total liabilities andstockholders' equity$322,455K Total stockholders'equity$304,555K Total liabilities$17,900K Accumulated deficit-$242,763K Additional paid-in capital$547,314K Total currentliabilities$10,603K Operating leaseliability, non-current...$6,768K Financing lease liability$529K Common stock, par value0.0001 - 500,000,000...$4K Accrued liabilities$4,734K Accounts payable$4,045K Operating leaseliability, current portion$1,253K Other currentliabilities$571K

Evommune, Inc. (EVMN)

Evommune, Inc. (EVMN)